English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
The 2023 Goldman Prize is awarded to Professor François Guilhot
March 2023 - Professor François Guilhot, an Emeritus Professor of Hematology and the past Director of the Clinical Investigation Center, 1402 INSERM in Poitiers, France, will receive the 2023 iCMLf Goldman Prize. Professor Guilhot receives the award in recognition of his pioneering achievements in important clinical trials in CML and his longstanding leadership in the management of CML. The annual Goldman Prize, awarded in honour of Professor John Goldman, acknowledges outstanding lifetime contributions to the management of patients with CML.
"Many great scientists have already received the John Goldman Prize. And I am very honoured to have been selected this year;this award recognizes 35 years of research and care for CML patients.” (Professor François Guilhot)
The 2023 iCMLf Prize is awarded to two Ukrainian hematologists - Kostyantyn Kotlyarchuk & Iryna Dyagil
March 2023 - The iCMLf Prize in 2023 recognizes the work of Ukrainian hematologists in this time of war and disruption. The iCMLf Directors and Advisors have chosen the two nominated Ukrainian hematologists to jointly accept this prize in 2023:
- Professor Iryna Dyagil
Head of the Department of Radiation Oncohematology, National Scientific Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine,
Kyiv (Ukraine) - Dr Kostyantyn Kotlyarchuk
Head of the Hematology Department SI ‘Institute of Blood Pathology and Transfusion Medicine NAMS’, Lviv (Ukraine)
The iCMLf Prize recognizes outstanding contributions to the improvement of CML under the challenging conditions of low- and middle-income countries with unequal access to monitoring and access.
iCMLf Conversation: Genomics and Mutations in CML – Assessment and Risk
You're invited to our next iCMLf Conversation on March 30th at 1.30 CEST!
March 2023 - We are delighted to share that Professor Susan Branford from SA Pathology in Adelaide will be the CML expert for our next iCMLf Conversation on Thursday, March 30 th at 1.30 pm Central European Summer Time. Join us for this live expert talk on Zoom to hear her talking about genomics and mutations in CML. Professor Branford will share her expertise on mutation assessment and significance in CML and will discuss the concept of genomically-based risk assessment in CML.
Reminder: An iCMLf Conversation on Management of advanced phases of CML
|
February 2022 - Do you have patients with advanced phases of CML? Would you like to hear first-hand from a CML expert on how best to manage these cases? Then, we invite you to join us for our next iCMLf Conversation, hosted by Professor Mhairi Copland from the University of Glasgow on Wednesday, February 22nd at 12pm Central European Time. During this first iCMLf Conversation of 2023, Professor Copland will share her expertise on the outcomes for blast phase CML, novel therapy options and provide guidance on how to best treat your CML patients in advanced stages of CML. |
Videos from the 2022 iCMLf Forum - Disease persistence, TKI resistance and other key challenges in CML
February 2022 - At the iCMLf Forum in December, we brought together a panel of leading experts and patient advocates to discuss the next big challenges and future directions in CML.
If you would like like to hear more about these key areas of research including; disease persistence in CML, treatment-free remission for all and TKI resistance in addition to BCR::ABL1 mutations – view the Forum videos on the iCMLf website.
We also take the opportunity to say a big THANK YOU to everyone who sent us the research questions that you believe need to be answered to help us move closer to a CML cure over the next 5-10 years.
Childhood Cancer Day & Experts Review Paediatric CML Management
Each year on the 15th of February, the world recognises International Childhood Cancer Day. A day that raises awareness about childhood cancer, and expresses support to those affected and their families, as well as recognising the need for more research and access to better care.
This year, the International CML Foundation is proud to share our part in providing access to up-to-date knowledge in paediatric CML practices, in hopes to thus create better care for children and young adults with CML around the world. So without further ado, we’re pleased to officially announce the launch of Phase II of the iCMLf Knowledge Centre and our first Module: Paediatric CML.
